Respectfully disagree. The ~15% (US) and <10% (WW) numbers I posted in this thread are pot'l %reductions in Mavyret's addressable mkt—not %reductions in ACTUAL SALES. If we presume that Mavyret wouldve gotten ~50% of ESRX biz, then %reduction in actual 2019 Mavyret sales is 3-4%.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.